Inаmed Corp., Inamed Development Co., and BioEnterics Corp. (collectively, “Inamed” or “appellants”) appeal from an order of the United States District Court for the Central District of California dismissing their action for declaratory judgment against defendant Lubomyr I. Kuzmak, M.D., for lack of personal jurisdiction. Inamed Corp. v. Kuzmak, No. 99-2160 (C.D.Cal. Feb. 24, 2000) (“Inamed Corp.”). Because we conclude that the district court erred in determining that it lacked personal jurisdiction over the defendant, we reverse and remand.
I
This appeal stems from a declaratory judgment action related to four patents directed to devices and methods for the surgical treatment of obesity. The defendant-appellee, Dr. Kuzmak, is listed as a co-inventor оf U.S. Patent No. 4,592,339 (“the '339 patent”), directed to an adjustable silicone gastric band used to constrict the size of a stomach, and U.S. Patent No. 4,696,288 (“the '288 patent”), directed to a method for performing gastric banding surgery using a calibrating tube and electronic sensor apparatus. Dr. Kuzmak is also listed as sole inventor of U.S. Patent No. 5,074,868 (“the '868 patent”), directed to a reversible gastric band, and U.S. Pat *1359 ent No. 5,226,429 (“the '429 patent”), directed to a method for performing a gastric banding operation via laparoscopic surgery. At all times relevant to this appeal, Dr. Kuzmak has been a resident of New Jersey. The appellants are all corporations with principal places of business in California.
Between 1989 and 1993, Inamed entered into four license agreements with Dr. Kuz-mak involving his four patents. The fourth agreement, dated July 1, 1993 (“the 1993 Agreement”), superseded the three previous agreements between Dr. Kuzmak and Inamed. The 1993 Agreement granted Inamed an exclusive license to practice all four patents in exchange for royalty feеs based on Inamed’s commercial exploitation of the patents. From 1992 to 1998, Inamed made annual royalty payments to Dr. Kuzmak of more than $1.3 million based on the sale of gastric bands manufactured in California by Inamed. In 1998, Inamed attempted to renegotiate the license agreement. When these negotiations proved unsuccessful, Inamеd terminated the contract on December 6, 1998.
Following the contract’s termination, Dr. Kuzmak sent a letter to Inamed, dated December 21, 1998, containing the following language concerning three of the four patents:
For the record, we should note that we do not concede that the '339 patent is invalid and would, in fact, contend that [Inamed] infringes valid claims of the '339 patent.
Regarding the '429 patent, [Inamed] is clearly a willful infringer of this patent.
It also appears from what we have seen that [Inamed] induces infringement of the '288 patent and thus that [Inamed] is currently a willful infringer of the '288 patent as well.
On February 26, 1999, Inamed commenced a declaratory judgment action against Dr. Kuzmak in California, seeking a dеclaration of patent invalidity, unen-forceability, and noninfringement. In-amed also alleged patent misuse and breach of contract. On April 5, 1999, Dr. Kuzmak filed a motion to dismiss for lack of personal jurisdiction. The district court subsequently found that Dr. Kuzmak’s contacts with California were not sufficient to support the exercise of either general or spеcific jurisdiction over him, and thus dismissed the action. Instrumental to the district court’s determination were the factual findings that Dr. Kuzmak’s license agreements with Inamed had already been terminated, and that Dr. Kuzmak conducted all discussions concerning these agreements via telephone and mail from New Jersey. Inamed Corp., slip. op. at 10. Inamed now appeals.
II
Whether a court has personal jurisdiction over a defendant is a question of law which we review
de novo. Dainippon Screen Mfg. Co. v. CFMT, Inc.,
Determining whether personal jurisdiction exists over an out-of-state defendant involves two inquiries: whether a forum state’s long-arm statute permits service of process, and whether the assertion of personal jurisdiction would violate due process.
Genetic Implant Sys., Inc. v.
*1360
Core-Vent Corp.,
In the seminal case on personal jurisdiction,
International Shoe Co. v. Washington,
In
Akro,
we summarized the Supreme Court’s jurisprudence by setting forth a three-factor test to determine whether asserting jurisdiction over an out-of-state defendant comports with due process. The three factors are: (1) whether the defendant “purposefully directed” its activities at residents of the forum; (2) whether the claim “arises out of or relates to” the defendant’s activities with the forum; and (3) whether assertion of personal jurisdiction is “reasonable and fair.”
Akro,
Inamed argues that Dr. Kuzmak’s various contacts and activities directed at California residents make him amenable to personal jurisdiction there. We agree.
A
In determining whether Dr. Kuzmak purposefully directed his activities at residents of California, the first and most important point of contact is the letter dated December 21, 1998, which Dr. Kuzmak sent to Inamed after the termination of their 1993 agreement. Although Dr. Kuz-mak, through his counsel, actually sent the infringement letter to Inamed’s attorney in New York, because Inamed’s attorney was Inamed’s agent for the purpose of receiving the correspondence, the fact that he was located in New York is immaterial.
See Akro,
Dr. Kuzmak contends that his letter should be ignored because it could not have created an “objectively reasonable apprehension” that suit will be brought against Inamed. However, the letter *1361 clearly asserts that Inamed willfully infringed at least two of Dr. Kuzmak's patents and alleges infringement оf another. The fact that Dr. Kuzmak chose to use the term "willful" in conjunction with "infringement" is significant. It indicates that he was aware-and perhaps intentionally communicating his awareness-of the treble damages and attorney fees to which he may be entitled in a successful infringement action against Inamed. See 35 U.S.C. §§ 284, 285 (1994). Hence, Dr. Kuzmak's challenge to the consideration of his infringement letter in our due process inquiry is simply without merit.
We have, however, repeatedly held that the sending of an infringement letter, without more, is insufficient to satisfy the requirements of due process when exercising jurisdiction over an out-of-state paten-tee.
See, e.g., Red Wing Shoe Co. v. Hockerson-Halberstadt, Inc.,
We thus consider whether there were “other activities” sufficient to meet the “minimum contacts” requirement of International Shoe. Dr. Kuzmak successfully negotiated four license agreements with Inamed based on his four patents. The 1993 Agreement, the last of the four agreements, granted Inamed an exclusive license to practice the inventions claimed in the '339, '288, and '868 patents. It also granted Inamed an exclusive license in what would ultimately issue as the '429 patеnt. Having agreed to pay a royalty fee based on its exploitation of the patents, Inamed made annual royalty payments from 1992 to 1998 to Dr. Kuzmak of more than $1.3 million based on the sale of gastric bands manufactured at Inamed’s facilities in California.
Dr. Kuzmak contends that his negotiation efforts and the ensuing license agreements are not sufficiеnt to demonstrate that he purposefully directed his activities at residents of California. The basis for his position is that, except for one “get acquainted” session in 1989, Dr. Kuzmak negotiated all of the agreements via telephone or mail from his home in New Jersey. However, as we pointed out at oral argument, the Supreme Court has explicitly rejected such rationale in its decision in
Quill Corp. v. North Dakota,
“Jurisdiction in these circumstances may not be avoided merely because the defendant did not physically enter the forum State.... [I]t is an inescapable fact of modern commercial life that a sub *1362 stantial amount of business is transacted solely by mail and wire communications across state lines, thus obviating the need for physical presence within a State in which business is conducted. So long as a commercial actor’s efforts are ‘purposefully directed’ toward residents of another State, we have consistently rejected the notion that an absence of physical contacts can defeat persоnal jurisdiction there.”
Id.
at 307-08,
B
Having concluded that Dr. Kuzmak purposefully directed his activities at Inamed, a California resident, we must determine whether Inamed’s claim arises out of or relates to Dr. Kuzmak’s activitiеs directed at the forum. There can be no dispute that the infringement letter satisfies this factor in the
Akro
test. The central purpose of a declaratory action is often to “clear the air of infringement charges.”
Red Wing,
Although Dr. Kuzmak does not dispute the relatеdness of the infringement letter, he contends that Inamed’s claim does not “arise from or relate to” his prior negotiations and license agreements with Inamed, at least partly because the agreements had been terminated by the time he sent the infringement letter. We disagree. Although the nexus necessary to satisfy the “arise out of or related to” requirement of the due process inquiry has not been clearly delineated by the Supreme Court, we have stated that it is significant that the constitutional catch-phrase is disjunctive in nature, indicating an added flexibility and signaling a relaxation of the applicable standard from a pure “arise out of’ standard.
Akro,
C
Once the first two factors of the
Akro
test have been satisfied by Inamed, the burden shifts to Dr. Kuzmak to convince us that the exercise of рersonal jurisdiction over him is not “reasonable and fair.”
Akro,
In addressing the “reasonableness” of exercising jurisdiction, the Supreme Court has stated that the inquiry would depend on an evaluation of several factors: (1) the burden on the defendant, (2) the interests of the forum State, (3) the plaintiffs interest in obtaining relief, (4) the interstate judicial system’s interest in obtaining the most efficient resolution of controversies, and (5) the shared interest of the several States in furthering fundamental substantive social policies.
Asahi Metal Indus. Co. v. Super. Ct. of Cal.,
Dr. Kuzmak argues that the exercise of jurisdiction over him by a district court in California is unreasonable because he “has been quite ill for somе time with back injuries resulting from an accident and he is unable to stand or sit for longer than one-half hour at a time and he is unable to travel distances.” This argument, even if true, does not dictate a denial of jurisdiction as a matter of constitutional right. Alternative means are available to Dr. Kuzmak through which he can obtain relief, such as filing for a changе in venue or making a motion of forum non conveniens. As we reiterated in Akro:
Where a defendant who purposefully has directed his activities at forum residents seeks to defeat jurisdiction, he must present a compelling case that the presence of some other considerations would render jurisdiction unreasonable. Most such considerations usually may be accommodаted through means short of finding jurisdiction unconstitutional. For example, ... a defendant claiming substantial inconvenience may seek a change of venue.
Id.,
We have considered the parties’ other arguments and find that they arе either unpersuasive or unnecessary for resolution of this appeal. Hence, because the district court erred in concluding that Dr. Kuz-mak’s act of sending an infringement letter to Inamed and his efforts in the negotiations leading to their license agreement were not sufficient contacts to satisfy the constitutional requirements of due process, we reverse its dismissal for lack of personal jurisdiction and remand for further proceedings consistent with this opinion.
REVERSED and REMANDED.
